The potential benefit of endothelin receptor antagonists’ therapy in idiopathic pulmonary fibrosis: A meta-analysis of results from randomized controlled trials – Medicine
The post M-A | Endothelin receptor antagonists do not improve outcomes in idiopathic pulmonary fibrosis. appeared first on Links Medicus.